Email this page: News Release
Affymax and Takeda Announce FDA Approval of OMONTYS® (Peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis
To (email address):
Separate multiple addresses with commas. Maximum 200 characters.
Your email address:
These email addresses will be used to email the page on your behalf and will not be used by Affymax, Inc. for any marketing purposes.
Add a comment:
Link to page
Type in number:
This helps Affymax, Inc. prevent automated submissions.